Published in Cancer Causes Control on October 01, 2005
The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health (2009) 9.79
Obesity is an independent prognostic variable in colon cancer survivors. Clin Cancer Res (2010) 2.18
Obesity and risk of colorectal cancer: a systematic review of prospective studies. PLoS One (2013) 2.02
Body size and thyroid cancer in two million Norwegian men and women. Br J Cancer (2006) 1.80
Meta-analyses of colorectal cancer risk factors. Cancer Causes Control (2013) 1.42
Obesity and the risk of gallbladder cancer: a meta-analysis. Br J Cancer (2007) 1.28
Association between body mass index and colorectal neoplasia at follow-up colonoscopy: a pooling study. Am J Epidemiol (2009) 1.21
Body mass index and risk of colorectal cancer according to fatty acid synthase expression in the nurses' health study. J Natl Cancer Inst (2012) 1.19
Excess body weight and obesity--the link with gastrointestinal and hepatobiliary cancer. Nat Rev Gastroenterol Hepatol (2011) 1.18
Body size and incident colorectal cancer: a prospective study of older women. Cancer Prev Res (Phila) (2010) 0.98
Body mass index and cancer incidence: the FINRISK study. Eur J Epidemiol (2014) 0.98
Body size and the risk of biliary tract cancer: a population-based study in China. Br J Cancer (2008) 0.98
Association between visceral adiposity and colorectal polyps on CT colonography. AJR Am J Roentgenol (2012) 0.97
Prospective investigation of body mass index, colorectal adenoma, and colorectal cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. J Clin Oncol (2013) 0.95
Body fatness during childhood and adolescence, adult height, and risk of colorectal adenoma in women. Cancer Prev Res (Phila) (2011) 0.95
A prospective study on metabolic risk factors and gallbladder cancer in the metabolic syndrome and cancer (Me-Can) collaborative study. PLoS One (2014) 0.92
Comparative cellular biogerontology: primer and prospectus. Ageing Res Rev (2010) 0.89
Pooled cohort study on height and risk of cancer and cancer death. Cancer Causes Control (2013) 0.88
Direct healthcare cost of obesity in brazil: an application of the cost-of-illness method from the perspective of the public health system in 2011. PLoS One (2015) 0.88
Height and body mass index in relation to cancer of the small intestine in two million Norwegian men and women. Br J Cancer (2005) 0.86
Can weight loss prevent cancer? Br J Cancer (2008) 0.84
Body Mass Index and Risk of Gallbladder Cancer: Systematic Review and Meta-Analysis of Observational Studies. Nutrients (2015) 0.83
Mendelian randomization study of height and risk of colorectal cancer. Int J Epidemiol (2015) 0.83
Assessing individual risk for high-risk colorectal adenoma at first-time screening colonoscopy. Int J Cancer (2015) 0.81
The association between BMI and gallbladder cancer risk: a meta-analysis. Oncotarget (2016) 0.80
Height as an independent anthropomorphic risk factor for colorectal cancer. Eur J Gastroenterol Hepatol (2014) 0.76
Body Mass Index Can Increase the Risk of Gallbladder Cancer: A Meta-Analysis of 14 Cohort Studies. Med Sci Monit Basic Res (2016) 0.75
Association between Adult Height and Risk of Colorectal, Lung, and Prostate Cancer: Results from Meta-analyses of Prospective Studies and Mendelian Randomization Analyses. PLoS Med (2016) 0.75
Body Size Indicators and Risk of Gallbladder Cancer: Pooled Analysis of Individual-Level Data from 19 Prospective Cohort Studies. Cancer Epidemiol Biomarkers Prev (2017) 0.75
Analysis of the height dependence of site-specific cancer risk in relation to organ mass. Ann Transl Med (2016) 0.75
Height and lung cancer risk: A meta-analysis of observational studies. PLoS One (2017) 0.75
Increasing twinning rates in Norway, 1967-2004: the influence of maternal age and assisted reproductive technology (ART). Acta Obstet Gynecol Scand (2007) 2.13
Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries. J Natl Cancer Inst (2007) 2.08
Vitamin D3 from sunlight may improve the prognosis of breast-, colon- and prostate cancer (Norway). Cancer Causes Control (2004) 2.04
Oncological outcomes after total mesorectal excision for cure for cancer of the lower rectum: anterior vs. abdominoperineal resection. Dis Colon Rectum (2004) 2.01
Familial risks in nervous-system tumours: a histology-specific analysis from Sweden and Norway. Lancet Oncol (2009) 1.95
Blood glucose and risk of incident and fatal cancer in the metabolic syndrome and cancer project (me-can): analysis of six prospective cohorts. PLoS Med (2009) 1.83
Testicular cancer incidence in eight northern European countries: secular and recent trends. Cancer Epidemiol Biomarkers Prev (2004) 1.82
Body mass index in adolescence in relation to total mortality: 32-year follow-up of 227,000 Norwegian boys and girls. Am J Epidemiol (2003) 1.79
Obesity in adolescence and adulthood and the risk of adult mortality. Epidemiology (2004) 1.73
Height and body mass index in relation to total mortality. Epidemiology (2003) 1.70
The cumulative risk of a false-positive recall in the Norwegian Breast Cancer Screening Program. Cancer (2004) 1.62
Risk factors for hypospadias in Norwegian boys - association with testicular dysgenesis syndrome? Int J Androl (2004) 1.61
Height, body mass index, and ovarian cancer: a follow-up of 1.1 million Norwegian women. J Natl Cancer Inst (2003) 1.55
Relation of height and body mass index to renal cell carcinoma in two million Norwegian men and women. Am J Epidemiol (2004) 1.54
Height and body mass index in relation to esophageal cancer; 23-year follow-up of two million Norwegian men and women. Cancer Causes Control (2004) 1.51
Head circumference at birth and risk of brain cancer in childhood: a population-based study. Lancet Oncol (2006) 1.50
Breast cancer tumor growth estimated through mammography screening data. Breast Cancer Res (2008) 1.43
Body size in relation to cancer of the uterine corpus in 1 million Norwegian women. Int J Cancer (2007) 1.43
Age-incidence curves of nasopharyngeal carcinoma worldwide: bimodality in low-risk populations and aetiologic implications. Cancer Epidemiol Biomarkers Prev (2008) 1.38
Metabolic syndrome and breast cancer in the me-can (metabolic syndrome and cancer) project. Cancer Epidemiol Biomarkers Prev (2010) 1.37
Metabolic profile, physical activity, and mortality in breast cancer patients. Breast Cancer Res Treat (2009) 1.36
Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults. Int J Cancer (2011) 1.31
Estimating mean sojourn time and screening test sensitivity in breast cancer mammography screening: new results. J Med Screen (2005) 1.29
Breast cancer mortality in participants of the Norwegian Breast Cancer Screening Program. Cancer (2013) 1.25
Cancer's impact on employment and earnings--a population-based study from Norway. J Cancer Surviv (2008) 1.20
Risk of diabetes after gestational diabetes and preeclampsia. A registry-based study of 230,000 women in Norway. Eur J Epidemiol (2011) 1.19
Height and body mass index and risk of lymphohematopoietic malignancies in two million Norwegian men and women. Am J Epidemiol (2006) 1.17
Cancer risk in children with birth defects and in their families: a population based cohort study of 5.2 million children from Norway and Sweden. Cancer Epidemiol Biomarkers Prev (2008) 1.16
Frailty modelling of testicular cancer incidence using Scandinavian data. Biostatistics (2004) 1.15
Metabolic factors and risk of thyroid cancer in the Metabolic syndrome and Cancer project (Me-Can). Cancer Causes Control (2011) 1.14
Cohort Profile: The Metabolic syndrome and Cancer project (Me-Can). Int J Epidemiol (2009) 1.12
Metabolic risk factors and cervical cancer in the metabolic syndrome and cancer project (Me-Can). Gynecol Oncol (2012) 1.11
Prospective study on metabolic factors and risk of prostate cancer. Cancer (2012) 1.09
Validation of disease registration in pregnant women in the Medical Birth Registry of Norway. Acta Obstet Gynecol Scand (2009) 1.08
Estimating mean sojourn time and screening sensitivity using questionnaire data on time since previous screening. J Med Screen (2008) 1.05
Parenthood after cancer - a population-based study. Psychooncology (2007) 1.05
Frailty modelling of colorectal cancer incidence in Norway: indications that individual heterogeneity in risk is related to birth cohort. Eur J Epidemiol (2006) 1.05
Risk of bilateral renal cell cancer. J Clin Oncol (2009) 1.04
Blood pressure and risk of cancer incidence and mortality in the Metabolic Syndrome and Cancer Project. Hypertension (2012) 1.04
Solar radiation, vitamin D and survival rate of colon cancer in Norway. J Photochem Photobiol B (2005) 1.04
Metabolic factors and the risk of pancreatic cancer: a prospective analysis of almost 580,000 men and women in the Metabolic Syndrome and Cancer Project. Cancer Epidemiol Biomarkers Prev (2010) 1.03
Serum triglycerides and cancer risk in the metabolic syndrome and cancer (Me-Can) collaborative study. Cancer Causes Control (2010) 1.01
Fetal growth and childhood cancer: a population-based study. Pediatrics (2013) 1.01
A prospective study of body mass index, weight change, and risk of cancer in the proximal and distal colon. Cancer Epidemiol Biomarkers Prev (2010) 1.00
Metabolic factors and the risk of colorectal cancer in 580,000 men and women in the metabolic syndrome and cancer project (Me-Can). Cancer (2010) 0.99
Metabolic syndrome and endometrial carcinoma. Am J Epidemiol (2010) 0.99
Blood pressure and other metabolic syndrome factors and risk of brain tumour in the large population-based Me-Can cohort study. J Hypertens (2012) 0.98
Conditions in utero and cancer risk. Eur J Epidemiol (2006) 0.98
Total serum cholesterol and cancer incidence in the Metabolic syndrome and Cancer Project (Me-Can). PLoS One (2013) 0.98
Vitamin D, season, and risk of prostate cancer: a nested case-control study within Norwegian health studies. Am J Clin Nutr (2012) 0.98
The impact of height and body mass index on the risk of testicular cancer in 600,000 Norwegian men. Cancer Causes Control (2006) 0.98
Metabolic syndrome and risk of bladder cancer: prospective cohort study in the metabolic syndrome and cancer project (Me-Can). Int J Cancer (2011) 0.96
Risk of thyroid cancer in first-degree relatives of patients with non-medullary thyroid cancer by histology type and age at diagnosis: a joint study from five Nordic countries. J Med Genet (2013) 0.95
Metabolic risk factors for esophageal squamous cell carcinoma and adenocarcinoma: a prospective study of 580,000 subjects within the Me-Can project. BMC Cancer (2014) 0.95
Sarcosine and other metabolites along the choline oxidation pathway in relation to prostate cancer--a large nested case-control study within the JANUS cohort in Norway. Int J Cancer (2013) 0.94
Biomarkers related to one-carbon metabolism as potential risk factors for distal colorectal adenomas. Cancer Epidemiol Biomarkers Prev (2011) 0.94
Nested case-control study of the association of circulating levels of serum insulin-like growth factor I and insulin-like growth factor binding protein 3 with breast cancer in young women in Norway. Cancer Epidemiol Biomarkers Prev (2008) 0.93
Size at birth and risk of breast cancer: prospective population-based study. Int J Cancer (2005) 0.93
Breast cancer incidence in Mongolia. Cancer Causes Control (2012) 0.92
Metabolic risk factors and ovarian cancer in the Metabolic Syndrome and Cancer project. Int J Epidemiol (2011) 0.92
Frailty modeling of the bimodal age-incidence of Hodgkin lymphoma in the Nordic countries. Cancer Epidemiol Biomarkers Prev (2011) 0.92
Reproductive history and the risk of molecular breast cancer subtypes in a prospective study of Norwegian women. Cancer Causes Control (2014) 0.92
A hierarchical frailty model for familial testicular germ-cell tumors. Am J Epidemiol (2013) 0.91
p16INK4a and p21Waf1/Cip1 expression correlates with clinical outcome in vulvar carcinomas. Gynecol Oncol (2004) 0.90
The associations of obesity, lymph node status and prognosis in breast cancer patients: dependence on estrogen and progesterone receptor status. APMIS (2004) 0.90
Prostate cancer, prostate cancer death, and death from other causes, among men with metabolic aberrations. Epidemiology (2014) 0.89
Metabolic factors associated with risk of renal cell carcinoma. PLoS One (2013) 0.89
The impact of cancer on spouses' labor earnings: a population-based study. Cancer (2009) 0.88
Pooled cohort study on height and risk of cancer and cancer death. Cancer Causes Control (2013) 0.88
Serum folate and vitamin B12 concentrations in relation to prostate cancer risk--a Norwegian population-based nested case-control study of 3000 cases and 3000 controls within the JANUS cohort. Int J Epidemiol (2013) 0.87
Does cancer in a child affect parents' employment and earnings? A population-based study. Cancer Epidemiol (2010) 0.86
Comparison of recorded medication use in the Medical Birth Registry of Norway with prescribed medicines registered in the Norwegian Prescription Database. Pharmacoepidemiol Drug Saf (2010) 0.86
Overdiagnosis of invasive breast cancer due to mammography screening. Ann Intern Med (2012) 0.85
Tuberculin status, socioeconomic differences and differences in all-cause mortality: experience from Norwegian cohorts born 1910-49. Int J Epidemiol (2009) 0.85
Estimating screening test sensitivity and tumour progression using tumour size and time since previous screening. Stat Methods Med Res (2010) 0.85
Consumption of berries, fruits and vegetables and mortality among 10,000 Norwegian men followed for four decades. Eur J Nutr (2014) 0.85
The Inverse Relationship between 25-Hydroxyvitamin D and Cancer Survival: Discussion of Causation. Cancers (Basel) (2013) 0.85
Homogeneous prostate cancer mortality in the Nordic countries over four decades. Eur Urol (2010) 0.85
Prospective cohort study of metabolic risk factors and gastric adenocarcinoma risk in the Metabolic Syndrome and Cancer Project (Me-Can). Cancer Causes Control (2012) 0.84